Abstract
Between 1958-1983, 79 patients with a diagnosis of epithelial tumor of the nasopharynx received definitive irradiation at Thomas Jefferson University Hospital. Seventy-two percent of the patients had a Stage IV lesion. The dose to the nasopharynx was over 6,000 cGy in all but four patients. The 5- and 10-year actuarial survivals were 33% and 19% respectively. The 5-year disease-free survival was 33%. Histology had no bearing on survival. Survival was influenced by the stage of primary tumor and nodes. Advanced nodal disease correlated with distant metastasis, being present in 13/15 cases with hematogenous spread.
| Original language | English |
|---|---|
| Pages (from-to) | 384-392 |
| Number of pages | 9 |
| Journal | American Journal of Clinical Oncology: Cancer Clinical Trials |
| Volume | 8 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1985 |
Keywords
- Adolescent
- Adult
- Aged
- Carcinoma, Squamous Cell/mortality
- Female
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Nasopharyngeal Neoplasms/mortality
- Neoplasm Recurrence, Local
- Radiotherapy, High-Energy/adverse effects
- Time Factors